AIFM2 and lung adenocarcinoma: On the other hand, low expression of both GPX4 and FSP1 was associated with poor prognosis in lung squamous cell carcinoma [11], whereas low expression of GPX4 alone was associated with poor prognosis in lung adenocarcinoma.